Identification, Expression, and Substrate Specificity of a Mammalian beta -Carotene 15,15'-Dioxygenase*

T. Michael RedmondDagger §, Susan GentlemanDagger , Todd DuncanDagger , Shirley YuDagger , Barbara WiggertDagger , Elisabeth Gantt, and Francis X. Cunningham Jr.

From the Dagger  Laboratory of Retinal Cell and Molecular Biology, NEI, National Institutes of Health, Bethesda, Maryland 20892 and the  Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland 20742

Received for publication, October 3, 2000, and in revised form, November 20, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have identified from mouse the first mammalian beta -carotene 15,15'-dioxygenase (beta -CD), a crucial enzyme in development and metabolism that governs the de novo entry of vitamin A from plant-derived precursors. beta -CD is related to the retinal pigment epithelium-expressed protein RPE65 and belongs to a diverse family that includes the plant 9-cis-epoxycarotenoid dioxygenase and bacterial lignostilbene dioxygenases. beta -CD expression in Escherichia coli cells engineered to produce beta -carotene led to the accumulation of all-trans-retinal at the expense of beta -carotene, confirming that beta -CD catalyzed the central cleavage of this vitamin A precursor. Purified recombinant beta -CD protein cleaves beta -carotene in vitro with a Vmax of 36 pmol of retinal/mg of enzyme/min and a Km of 6 µM. Non-provitamin A carotenoids were also cleaved, although with much lower activity. By Northern analysis, a 2.4-kilobase (kb) message was observed in liver, kidney, small intestine, and testis, tissues important in retinoid/carotenoid metabolism. This message encoded a 63-kDa cytosolic protein expressed in these tissues. A shorter transcript of 1.8 kb was found in testis and skin. Developmentally, the 2.4-kb mRNA was abundant at embryonic day 7, with lower expression at embryonic days 11, 13, and 15, suggesting a critical role for this enzyme in gastrulation. Identification of beta -CD in an accessible model organism will create new opportunities to study vitamin A metabolism.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In vertebrates, vitamin A in its various oxidative and isomeric forms is essential for embryonic development (1), pattern formation (2, 3), and vision (4). Retinoic acid, through its interaction with the nuclear retinoic acid receptor and retinoid X receptor, profoundly affects cell differentiation and development. Because animals are unable to synthesize vitamin A de novo from endogenous isoprenoid precursors, they must instead derive it from cleavage of beta -carotene and certain other carotenoids with an unsubstituted beta -ring (e.g. gamma - and alpha -carotenes, beta -zeacarotene, and beta -cryptoxanthin). It is generally accepted that central cleavage of beta -carotene by a putative dioxygenase gives rise to two molecules of all-trans-retinal, whereas eccentric cleavage with subsequent processing leading to a single molecule of retinoic acid from an apocarotenal is quantitatively far less important (5). beta -Carotene cleavage activity is reported highest in the intestinal mucosa, but is found at high activity levels in liver, kidney, lung, and fat tissues, among other sites. However, an inability to purify the protein catalyzing this reaction has hindered thorough investigation of this crucial first step in vitamin A metabolism.

Because of a loose similarity between the mammalian protein RPE65 and the neoxanthin cleavage enzymes of plants, our laboratories have considered the hypothesis that the putative beta -CD1 would belong to an emerging family of carotenoid-cleaving dioxygenases known mainly from examples in plants (6), but with members also in bacteria and Metazoa. The first described representative was a bacterial lignostilbene alpha ,beta -dioxygenase, which cleaves the central carbon-carbon double bond of lignostilbene, a bicyclic lignin model compound, into two molecules of vanillin (7). The initial plant representative of this family is maize VP14, the neoxanthin cleavage enzyme of the abscisic acid pathway (8) that is a 9-cis-epoxycarotenoid dioxygenase (9). The essential similarity of these disparate reactions is shown in Fig. 1.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Signature reactions of three members of a diverse dioxygenase enzyme family. Arrows indicate the double bond cleaved. Upper panel, lignostilbene alpha ,beta -dioxygenase (LSD) (39); middle panel, 9-cis-epoxycarotenoid dioxygenase (VP14) (8); lower panel, beta -CD (this work).

The original animal representative of the family is RPE65, a protein restricted in its expression to the retinal pigment epithelium (10, 11). Although the specific biochemical function of RPE65 is not yet known, it is required for the all-trans- to 11-cis-isomerization reaction that regenerates the 11-cis-retinal chromophore of rhodopsin in the visual cycle of the retina (12). A thematic feature of the eukaryotic members of the family therefore appears to be an interaction with carotenoids or carotenoid derivatives to cleave or otherwise alter conjugated carbon-carbon double bonds. We used iterative searching of the genomic and EST data bases to find genes encoding polypeptides similar in sequence to RPE65. We describe here the characterization of one such RPE65 homolog from mouse, detail the developmental and tissue specificity of its expression, and define its enzymatic activity and substrate specificity. The protein does indeed cleave beta -carotene to produce all-trans-retinal, is related, although not closely, to a beta -CD recently identified from Drosophila melanogaster (13), and is of the same family as the recently described chicken beta -carotene 15,15'-dioxygenase (14). Identification of the mouse beta -CD protein and its gene provides the requisite tools for study of early steps of mammalian carotenoid metabolism in an accessible model system and gives additional insights into an ancient family of retinoid/carotenoid-metabolizing enzymes.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of a cDNA Encoding Mouse beta -CD-- A number of cDNAs encoding polypeptides similar in sequence to RPE65, VP14, and lignostilbene alpha ,beta -dioxygenase were detected by iterative tBLASTn (15) searches of the data base of expressed sequence tags (dbEST) and GenBankTM non-redundant Data Banks. Of several IMAGE Consortium ESTs examined, AW044715 (Incyte Genomics, St. Louis, MO) appeared, by comparison with RPE65, to be of sufficient length to specify the full-length polypeptide and was sequenced. Alignment of the deduced polypeptide with other metazoan dioxygenases and RPE65 proteins was done with ClustalW Version 1.74 using a gap opening penalty of 40 and a gap extension penalty of 0.1; the matrix used was the Blosum series.

Escherichia coli Expression of the Prospective Mouse beta -CD-- The open reading frame of the AW044715 clone was amplified using the forward primer 5'-ATG GAG ATA ATA TTT GGC CAG-3' and the reverse primer 5'-GCT CTA GAT TAA AGA CTT GAG CCA CCA TG-3'. An amplification product of the expected length was cloned into the expression vector pBAD/TOPO (Invitrogen, Carlsbad, CA) following the manufacturer's protocol to make the recombinant clone pBAD/beta -CD. The resultant recombinant clones were isolated and sequenced to verify orientation and sequence. Expression of beta -CD was induced as follows. Overnight cultures of E. coli containing pBAD/beta -CD were grown in LB broth supplemented with 100 µg/ml ampicillin (LB/ampicillin). These cultures were used to inoculate 5-ml LB/ampicillin cultures. At mid-log phase, expression of beta -CD was induced with serial dilutions of L-arabinose. Control cultures received distilled H2O in lieu of arabinose. Cultures were incubated for an additional 4 h, and aliquots were harvested by centrifugation. Accumulation of the expressed beta -CD protein was assayed by SDS-polyacrylamide gel electrophoresis (16) followed by immunoblotting (17) with detection using a specific antiserum to a peptide sequence within mouse beta -CD (see below).

Assay of Cleavage Activity of Mouse beta -CD Expressed in E. coli-- The pBAD/beta -CD expression construct was transformed into competent cells prepared as described (18) from a variety of carotenoid-accumulating strains of E. coli. Strains of E. coli that produce and accumulate lycopene and beta -carotene have been described (19, 20). Strains that produce delta - and epsilon -carotenes were constructed by inserting an Arabidopsis mono-epsilon -cyclase (21) or a lettuce di-epsilon -cyclase cDNA2 into a unique site in the plasmid that confers the ability to produce lycopene. Culture tubes containing 5 ml of LB broth (with 150 µg/ml ampicillin and 30 µg/ml chloramphenicol) were each inoculated with a single fresh colony and shaken overnight at 28 °C in darkness. One ml of the overnight cultures was used to inoculate 50 ml of LB broth (with ampicillin and chloramphenicol) in 250-ml flasks. Arabinose was added to a final concentration of 0.2%, and the cultures were grown at 28 °C in darkness with shaking for 48 h. Cells were harvested by centrifugation, and the pellets were extracted immediately or frozen at -20 °C for up to 1 week before extraction. Cultures of E. coli with cells transformed with the cloning vector containing an irrelevant insert (pBAD/lacZ) served as controls. Carotenoids and retinoids were extracted from the bacterial pellets by the method of von Lintig and Vogt (13). Recombinant pBAD/beta -CD protein, containing a His tag fusion, was purified using His-bind resin (Novagen, Madison, WI) from arabinose-induced cultures solubilized with B-PER reagent (Pierce).

HPLC Analysis of beta -Carotene and Retinal-- HPLC analysis of hexane extracts of the bacterial cultures was carried out on a Waters system consisting of a Model 600E pump, Model 717 autosampler, and Model 996 photodiode array detector. Separation was achieved by isocratic elution on a LiChrosphere Si-60 column (5 µm, 3.2 × 250 mm) with a mobile phase consisting of 6% 1,4-dioxane in hexane at a flow rate of 1 ml/min. Data acquisition and processing were done with Millennium32 Chromatography Manager Version 3.05 software (Waters). All solvents were HPLC-grade (Aldrich). Standards of beta -carotene, lycopene, and all-trans-retinal were obtained from Sigma.

Kinetic Analysis of Mouse beta -CD Enzymatic Activity-- The His-tagged recombinant pBAD/beta -CD protein was prepared for assay by dialysis in the presence of B-PER detergent extract of untransformed TOP10 (Invitrogen) E. coli cells (100 µl of a 5× concentration in B-PER of an overnight culture in LB broth per 10 µg of recombinant protein) against a buffer containing 0.1 M Tricine-KOH (pH 8.0), 0.1 M NaCl, 0.5% Triton X-100, 5 mM (tris(2-carboxyethyl)-phosphine hydrochloride) (Pierce), 10 µM FeSO4, and one Complete EDTA-free protease inhibitor mixture tablet (Roche Molecular Biochemicals) per 25 ml. The standard assay was carried out in this buffer (without the protease inhibitor) in a reaction volume of 0.4 ml at 37 °C for 2 h with 10 µg of recombinant enzyme using a substrate concentration range of 0-30 µM. The concentration of retinal was measured by HPLC as described above. Under these conditions, enzymatic activity was linear with enzyme concentration up to 35 µg/ml and with time up to 3 h.

Antiserum to Mouse beta -CD and Immunoblotting-- A multiple antigenic peptide (22) with the sequence NYIRKIDPQTLETLEK, corresponding to amino acids 142-157 of mouse beta -CD, was synthesized (Princeton Biomolecules, Langhorne, PA) and used to immunize rabbits. Serum was harvested and stored at -20 °C. This antibody was used at a final dilution of 1:5000 in 3% bovine serum albumin and 0.05% Tween 20 in phosphate-buffered saline (TPBS). The secondary antibody was alkaline phosphatase-conjugated goat anti-rabbit IgG (Life Technologies, Inc.) used at a dilution of 1:3000 in 3% bovine serum albumin and TPBS. Immunoreactive bands were detected using the one-component 5-bromo-4-chloro-3-indolyl phosphate/p-nitro blue tetrazolium phosphatase substrate solution (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD).

RNA Gel Blot Analysis of Mouse beta -CD mRNA Expression-- The open reading frame of mouse beta -CD was amplified using the forward primer 5'-CGG AAT TCC ATG GAG ATA ATA TTT GGC CAG-3' and the reverse primer 5'-GCT CTA GAT TAA AGA CTT GAG CCA CCA TG-3' in a reaction employing the high fidelity DNA polymerase Pfu Turbo (Stratagene, La Jolla, CA). The forward and reverse primers contain restriction sites (underlined) for EcoRI and XbaI, respectively. Following double digestion with these enzymes and subsequent phenol/chloroform extraction, the resultant fragment was directionally cloned into pBluescript II SK- digested with the same enzymes. To generate template for riboprobe transcription reactions, the pBluescript/beta -CD clone was digested with EcoRV, and the 3.9-kilobase pair band containing the 3'-end of the beta -CD cDNA followed by an inverted T3 promoter site was separated by agarose electrophoresis and purified by binding to Qiaex resin (QIAGEN Inc., Valencia, CA). The purified linearized template was used in a Strip E-Z (Ambion Inc., Austin, TX) in vitro runoff transcription reaction to produce [alpha -32P]UTP-labeled antisense riboprobe. The labeled riboprobe was used in RNA hybridizations (NorthernMax system, Ambion Inc.) of mouse multiple tissue (Origene, Gaithersburg, MD) and mouse embryonic development stage (CLONTECH, Palo Alto, CA) Northern blots. Hybridization and washing followed the manufacturer's protocols (Ambion Inc.). Processed blots were exposed to Hyperfilm MP autoradiographic film (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, United Kingdom).

Subcellular Fractionation of Mouse Tissues-- Freshly dissected kidney, liver, lung, testis, and small intestine were homogenized in 10 volumes of PBS containing one Complete protease inhibitor mixture tablet per 25 ml. The homogenate was centrifuged for 10 min at 1000 × g, and the low speed supernatant was recentrifuged for 15 min at 30,000 × g. The resulting supernatant was then centrifuged at 55,000 rpm for 30 min in a Beckman TL-100 tabletop ultracentrifuge using a TLA-100.2 fixed angle rotor. The supernatant was reserved, and the pellet was resuspended in 0.2 volume of homogenizing buffer. These samples were analyzed by SDS-polyacrylamide gel electrophoresis and immunoblotting using the conditions described above.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification and Characterization of a cDNA Encoding Mouse beta -CD-- Iterative tBLASTn searches of the dbEST division of the GenBankTM/EBI Data Bank using bovine RPE65 (accession number L11356) as the query sequence identified an EST (AW044715) showing 3'-similarity to RPE65, the maize epoxycarotenoid cleavage enzyme VP14, and the bacterial lignostilbene alpha ,beta -dioxygenase. The 2120-base pair cDNA (deposited in the GenBankTM/EBI Data Bank under accession number AF271298) contains an open reading frame that is 1698 base pairs in length, encoding a protein 566 amino acids in length with a calculated molecular mass of 63,859 Da. The deduced polypeptide is without an obvious signal peptide, predicted transmembrane domains, or potential sites for N-linked glycosylation.

Alignment of the deduced mouse polypeptide with chicken beta -CD (GenBankTM/EBI accession number AJ271386), Drosophila beta -CD (accession number AB041507), and the predicted product of a human cDNA of unknown function (accession number AK001592) showed 70, 30, and 85% identities, respectively (Fig. 2). The human cDNA thus appears to be an ortholog of mouse beta -CD, and both are related to chicken beta -CD. The mouse polypeptide has only 37% amino acid identity to mouse RPE65. Ten residues, including 4 histidine residues and 6 acidic residues, are absolutely conserved in these sequences, in all RPE65 proteins (Fig. 2), and in the plant 9-cis-epoxycarotenoid dioxygenases (8). In addition, there is a particularly well conserved region (consensus sequence EDDGVVLSXVVS) at residues 469-480 of mouse beta -CD that may be considered a family signature sequence. Besides the mouse sequence characterized herein, its presumptive human ortholog, and the chicken and Drosophila beta -CD proteins enumerated above, ESTs encoding presumptive orthologs from zebrafish and pig were noted as well as more distant family members from a variety of species. Because of the accessibility of the mouse as a model organism for further studies, we chose to specifically characterize the mouse gene.



View larger version (88K):
[in this window]
[in a new window]
 
Fig. 2.   Alignment of metazoan polyene chain dioxygenase family members. Histidine and acidic residues conserved throughout the superfamily are in boldface. The signature sequence is underlined. *, identity; :, strong similarity; ., weak similarity. GenBankTM/EBI accession numbers are as follows: human beta -CD, AK001592; mouse beta -CD, AF271298; chicken beta -CD, AJ271386; human RPE65, U18991; chicken RPE65, AB017594; and Drosophila beta -CD, AB041507. BCD, beta -CD.

Expression of Mouse beta -CD in E. coli-- Agar plate cultures of E. coli producing beta -carotene, epsilon -carotene, and lycopene and transformed with the pBAD/mouse beta -CD expression construct showed a distinct bleaching of the color when induced with L-arabinose (Fig. 3A). Cultures of bacteria containing pBAD/beta -CD were induced with a range of concentrations of L-arabinose in excess of 0.0002% (w/v) and analyzed by SDS-polyacrylamide gel electrophoresis and immunoblotting. A protein of the expected size of ~65 kDa was observed that was immunoreactive with the antiserum raised against the mouse beta -CD peptide epitope (Fig. 3B). The relevant His-tagged pBAD/mouse beta -CD fusion protein was purified using histidine affinity chromatography (data not shown).



View larger version (50K):
[in this window]
[in a new window]
 
Fig. 3.   Expression of mouse beta -CD in beta -carotene-, epsilon -carotene-, and lycopene-accumulating E. coli results in bleaching as a consequence of cleavage of the endogenous carotenoids. A, 10 µl of a 5% solution of arabinose was spotted in the center of the Petri plate at the time of inoculation. A gradient of bleaching, maximal near the center and least at the periphery, is apparent for the beta -carotene- and lycopene-accumulating strains. Bleaching of the epsilon -carotene strain is less pronounced. B, mid-log phase cultures of E. coli transformed with pBAD/beta -CD were induced with 0-0.2% L-arabinose, harvested and analyzed by SDS-polyacrylamide gel electrophoresis and immunoblotting as described under "Experimental Procedures." L-Arabinose induced a 65-kDa protein that interacted with the anti-beta -CD peptide antibody.

In Vivo and in Vitro Activity of Mouse beta -CD-- HPLC analysis of hexane extracts of beta -carotene-accumulating E. coli yielded the expected beta -carotene peak (Fig. 4A). Expression of mouse beta -CD in such cultures resulted in the appearance of all-trans-retinal with a concomitant loss of beta -carotene (Fig. 4B). The spectra of both the beta -carotene and all-trans-retinal peaks were analyzed (see insets in Fig. 4, A and B) and exhibited the expected shapes and absorbance maxima. beta -Carotene-, delta -carotene-, epsilon -carotene-, and lycopene-accumulating cultures, quantitated by HPLC analysis, showed 2.14, 1.87, 1.23, and 1.50 pmol/mg of bacterial protein, respectively, in cultures containing the empty vector. In contrast, cultures containing the mouse beta -CD insert had no detectable beta -carotene. However, delta -carotene, epsilon -carotene, and lycopene were present in such cultures at levels of 3.2, 57.9 and 65.6 fmol/mg of bacterial protein, respectively.



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   Detection of all-trans-retinal by HPLC of E. coli extracts. Organic extracts of E. coli cultures transformed with pBAD/beta -CD and induced with 0.2% arabinose were analyzed as described under "Experimental Procedures." A, cultures containing only the lacZ (control) construct accumulated beta -carotene. B, Cultures expressing mouse beta -CD produced all-trans-retinal. Solid lines, absorbance at 370 nm; dashed lines, absorbance at 450 nm. Insets, spectra of peaks indicated by asterisks. A beta -carotene (BC) standard eluted at 2.2 min; an all-trans-retinal (RAL) standard eluted at 7.4 min (not shown). AU, absorbance units.

Purified recombinant beta -CD protein cleaves beta -carotene in vitro with a Vmax of 36 pmol of retinal/mg of enzyme/min and a Km of 6 µM. At levels of lycopene concentrations comparable to the Km for beta -carotene, no acyclic retinal was detected. However, trace amounts were seen at 2.5-3 times the beta -carotene Km.

Expression of Mouse beta -CD in Tissues-- Multiple tissue RNA gel blots, analyzed with riboprobe, showed substantial steady-state mRNA levels in several of the tissues known to be active in vitamin A metabolism (Fig. 5A). The major message, seen in liver, kidney, testis, and small intestine, was 2.4 kb. Although the 2.4-kb message was in low abundance in the small intestine, a tissue known to contain strong beta -CD activity, it is likely that this was due to dilution of the mRNA contribution of the mucosa by that of the outer muscular layers of the gut. Smaller messages were also seen in testis and skin; in particular, a 1.8-kb message was quite abundant in testis. Analysis of a mouse developmental blot showed a strong signal for the 2.4-kb message at 7 days post-conception, which declined as the developmental age increased (Fig. 5B). In immunoblots, a band of immunoreactivity of the expected size of 63 kDa was detected in 30,000 × g and 100,000 × g supernatant fractions of liver, kidney, testis, and small intestine, but not in the 100,000 × g pellet fractions (data not shown).



View larger version (44K):
[in this window]
[in a new window]
 
Fig. 5.   Tissue and developmental expression of mRNA for mouse beta -CD. A, tissue distribution in adult mouse tissues. The blot was hybridized with a 3'-antisense riboprobe to mouse beta -CD. A transcript of 2.4 kb was noted in kidney, liver, small intestine (Sm. Intest.), and testis, whereas a transcript of 1.8 kb was seen in skin and testis. B, RNA gel blot of total mouse embryos from embryonic days 7-15. This blot was hybridized with the same probe as described for A. The 2.4-kb transcript was highly expressed at embryonic day 7 and less so at later embryonic stages.



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this report, we have described the catalytic activity and tissue-specific expression pattern of a mouse beta -CD. The protein clearly belongs to an extended family of dioxygenases that interact with carotenoids and other polyenes and that include the plant neoxanthin cleavage enzymes, the bacterial lignostilbene dioxygenases, and the vertebrate protein RPE65. The activity of mouse beta -CD seen with alternative carotenoid substrates (Fig. 3) indicates that the specificity of the catalytic activity is centered more in the polyene chain of the substrate than at the end groups. This observation is in accord with the activities previously reported for crude tissue preparations (23-25). Therefore, a more accurate and inclusive designation for the family as a whole may be the polyene chain dioxygenase family.

The conserved histidines and acidic residues of the various polyene dioxygenase family members are likely to be involved in coordinating the iron required for activity in these enzymes (9, 26). The signature sequence, a run of acidic residues connected through a glycine to a hydrophobic tail, could be involved in electron transfer processes during catalysis. Although the precise enzymatic activity of RPE65 has not yet been determined, RPE65 is capable of binding ferrous iron3 and thus shares this characteristic as well as the signature sequence with other family members. The resemblance of RPE65 to the other dioxygenase family members and the fact that its absence prevents the retinal pigment epithelium-specific isomerization of all-trans- to 11-cis-retinol in the visual cycle (12) suggest a direct catalytic participation in the visual cycle.

Although beta -CD activity in partially purified preparations from various sources has been localized both to cytosolic and membrane fractions, the overwhelming consensus is that it is a cytosolic protein (23-25, 27), as we also have found. However, an important aspect of the carotenoids and their derivatives as substrates is their lipophilicity (including a tendency to partition in membranes) and generally insoluble nature in aqueous solution. Interestingly, none of the polyene dioxygenase family members, including mouse beta -CD, are predicted to be integral membrane proteins. However, the plant 9-cis-epoxycarotenoid cleavage enzymes are associated with chloroplast membranes (9). The only metazoan member of the family whose biochemical properties have been examined in this respect is RPE65, which is a non-integral, microsomal membrane-associated protein, but can be separated from retinal pigment epithelium membranes by mild detergent or high salt extraction (11). Furthermore, RPE65 will specifically associate with phospholipid liposomes (28). It is possible that mouse beta -CD, despite its cytosolic nature, will also interact with membranes in the context of its physiological mechanism.

The tissue distribution of mouse beta -CD was, in general, as expected, although the level in the small intestine was somewhat weak. However, the beta -CD activity of this tissue is concentrated in mature enterocytes (and is highest in the jejunum) (29), which constitute a relatively small proportion of the total tissue used to provide the RNA for this blot. Thus, one possibility is that the weak signal in this tissue is due to dilution of the RNA with that from other cell types. Another possibility is that there is a tissue-specific beta -CD in small intestine, in addition to the one described here. The testis also is active in the uptake and metabolism of carotenoids, as beta -carotene and lycopene have been repeatedly demonstrated in testis (30-32). Cleavage of beta -carotene has been shown to be an important source of retinoic acid in vitro in testis as well as in small intestine, liver, kidney, and lung (33), and the high expression of beta -CD in testis noted here is consistent with this finding. Napoli and Race (33) have suggested that cleavage of beta -carotene may be an important source of retinoic acid in target tissues such as testis and may play an under-appreciated role in retinoid homeostasis.

Mouse beta -CD has a low level of activity toward carotenoids other than beta -carotene, including lycopene, observable in in vivo assays. As to its distribution, lycopene is accumulated primarily in liver, but also in intestine, prostate, and testis (34), and appears to have several biological activities (35). For example, in a recent study, lycopene, but not its acycloretinoid derivative, was effective in stimulating gap junction communication (36). Therefore, in this case, the function of the dioxygenase with respect to lycopene might be to terminate its activity.

The developmental expression of mouse beta -CD is particularly intriguing, given its early elevated expression at embryonic day 7 and much reduced expression thereafter. At embryonic day 7, with the embryo proceeding into gastrulation, a number of retinoids and retinoid-interacting proteins are being expressed (37). Analysis of endogenous retinoids in the mouse embryo (37) shows that all-trans-retinal is the first retinoid seen (at embryonic day 6.5), whereas both all-trans-retinoic acid and all-trans-retinol do not appear until embryonic day 7.5. In the mouse embryo, mRNAs of two dehydrogenases involved in retinoic acid production, alcohol dehydrogenase IV and aldehyde dehydrogenase I, are up-regulated between embryonic days 6.5 and 7.5 (37, 38). Although the early accumulation of all-trans-retinal may be due to low level activity of alcohol dehydrogenase IV on maternally supplied all-trans-retinol, there may also be a contribution from the cleavage of beta -carotene. Ulven et al. (37) suggested this possibility, an interpretation supported by our finding of high beta -CD mRNA expression at embryonic day 7. Thus, the activity of beta -CD could serve to produce all-trans-retinal from beta -carotene, a nontoxic provitamin source of retinoids in the early embryo.

The identification of mouse beta -CD establishes the existence in mammals of an ancient family of carotenoid-metabolizing enzymes. These enzymes, giving a means by which animals can cleave or modify these plant-derived compounds as required, provide access to retinoids for animals and facilitate their panoply of developmental and physiological effects. We can surmise that the adoption by animals of hormonally and otherwise physiologically active carotenoid metabolites (retinoids) was initially facilitated by such enzymes evolved from an ancient common ancestor.


    ACKNOWLEDGEMENT

We thank Dr. Rizwan Bhatti for help in the purification of the recombinant pBAD/beta -CD protein.


    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF271298.

§ To whom correspondence should be addressed: NEI-LRCMB, NIH, Bldg. 6, Rm. 339, 6 Center Dr. MSC 2740, Bethesda, MD 20892-2740. Tel.: 301-496-0439; Fax: 301-402-1883; E-mail: redmond@helix.nih.gov.

Published, JBC Papers in Press, November 22, 2000, DOI 10.1074/jbc.M009030200

2 F. X. Cunningham, Jr. and E. Gantt, manuscript in preparation.

3 S. Gentleman, unpublished data.


    ABBREVIATIONS

The abbreviations used are: beta -CD, beta -carotene 15,15'-dioxygenase; EST, expressed sequence tag; HPLC, high performance liquid chromatography; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; kb, kilobase(s).


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Morriss-Kay, G. M., and Ward, S. J. (1999) Int. Rev. Cytol. 188, 73-131[Medline] [Order article via Infotrieve]
2. Chen, Y., Huang, L., Russo, A. F., and Solursh, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10056-10059[Abstract]
3. Chen, Y., Huang, L., and Solursh, M. (1994) Dev. Biol. 161, 70-76[CrossRef][Medline] [Order article via Infotrieve]
4. Saari, J. C. (2000) Invest. Ophthalmol. Visual Sci. 41, 337-348[Free Full Text]
5. Nagao, A., During, A., Hoshino, C., Terao, J., and Olson, J. A. (1996) Arch. Biochem. Biophys. 328, 57-63[CrossRef][Medline] [Order article via Infotrieve]
6. Cunningham, F. X., Jr., and Gannt, E. (1998) Annu. Rev. Plant Physiol. Plant Mol. Biol. 49, 557-583[CrossRef]
7. Kamoda, S., and Saburi, Y. (1993) Biosci. Biotechnol. Biochem. 57, 926-930[Medline] [Order article via Infotrieve]
8. Tan, B. C., Schwartz, S. H., Zeevaart, J. A., and McCarty, D. R. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12235-12240[Abstract/Free Full Text]
9. Schwartz, S. H., Tan, B. C., Gage, D. A., Zeevaart, J. A., and McCarty, D. R. (1997) Science 276, 1872-1874[Abstract/Free Full Text]
10. Hamel, C. P., Tsilou, E., Pfeffer, B. A., Hooks, J. J., Detrick, B., and Redmond, T. M. (1993) J. Biol. Chem. 268, 15751-15757[Abstract/Free Full Text]
11. Hamel, C. P., Tsilou, E., Harris, E., Pfeffer, B. A., Hooks, J. J., Detrick, B., and Redmond, T. M. (1993) J. Neurosci. Res. 34, 414-425[Medline] [Order article via Infotrieve]
12. Redmond, T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J. X., Crouch, R. K., and Pfeifer, K. (1998) Nat. Genet. 20, 344-351[CrossRef][Medline] [Order article via Infotrieve]
13. von Lintig, J., and Vogt, K. (2000) J. Biol. Chem. 275, 11915-11920[Abstract/Free Full Text]
14. Wyss, A., Wirtz, G., Woggon, W., Brugger, R., Wyss, M., Friedlein, A., Bachmann, H., and Hunziker, W. (2000) Biochem. Biophys. Res. Commun. 271, 334-336[CrossRef][Medline] [Order article via Infotrieve]
15. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410[CrossRef][Medline] [Order article via Infotrieve]
16. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
17. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract]
18. Chung, C. T., Niemela, S. L., and Miller, R. H. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2172-2175[Abstract]
19. Sun, Z., Gantt, E., and Cunningham, F. X., Jr. (1996) J. Biol. Chem. 271, 24349-24352[Abstract/Free Full Text]
20. Cunningham, F. X., Jr., Pogson, B., Sun, Z., McDonald, K. A., DellaPenna, D., and Gantt, E. (1996) Plant Cell 8, 1613-1626[Abstract/Free Full Text]
21. Cunningham, F. X., Jr., Sun, Z., Chamovitz, D., Hirschberg, J., and Gantt, E. (1994) Plant Cell 6, 1107-1121[Abstract/Free Full Text]
22. Tam, J. P. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 5409-5413[Abstract]
23. Lakshmanan, M. R., Pope, J. L., and Olson, J. A. (1968) Biochem. Biophys. Res. Commun. 33, 347-352[Medline] [Order article via Infotrieve]
24. Olson, J. A. (1983) in Biosynthesis of Isoprenoid Compounds (Porter, J. W. , and Spurgeon, S. L., eds), Vol. 2 , pp. 371-412, John Wiley & Sons, Inc., New York
25. Singh, H., and Cama, H. R. (1974) Biochim. Biophys. Acta 370, 49-61[Medline] [Order article via Infotrieve]
26. Lakshman, M. R., and Okoh, C. (1993) Methods Enzymol. 214, 256-269[Medline] [Order article via Infotrieve]
27. Wolf, G. (1995) Nutr. Rev. 53, 134-137[Medline] [Order article via Infotrieve]
28. Tsilou, E., Hamel, C. P., Yu, S., and Redmond, T. M. (1997) Arch. Biochem. Biophys. 346, 21-27[CrossRef][Medline] [Order article via Infotrieve]
29. Duszka, C., Grolier, P., Azim, E. M., Alexandre-Gouabau, M. C., Borel, P., and Azais-Braesco, V. (1996) J. Nutr. 126, 2550-2556[Medline] [Order article via Infotrieve]
30. Yamanushi, T., and Igarashi, O. (1995) J. Nutr. Sci. Vitaminol. 41, 169-177[Medline] [Order article via Infotrieve]
31. Kerti, A., and Bardos, L. (1999) Acta Vet. Hung. 47, 95-101[Medline] [Order article via Infotrieve]
32. Stahl, W., Schwarz, W., Sundquist, A. R., and Sies, H. (1992) Arch. Biochem. Biophys. 294, 173-177[Medline] [Order article via Infotrieve]
33. Napoli, J. L., and Race, K. R. (1988) J. Biol. Chem. 263, 17372-17377[Abstract/Free Full Text]
34. Froescheis, O., Moalli, S., Liechti, H., and Bausch, J. (2000) J. Chromatogr. Biomed. Appl. 739, 291-299[CrossRef]
35. Clinton, S. K. (1998) Nutr. Rev. 56, 35-51[Medline] [Order article via Infotrieve]
36. Stahl, W., von Laar, J., Martin, H. D., Emmerich, T., and Sies, H. (2000) Arch. Biochem. Biophys. 373, 271-274[CrossRef][Medline] [Order article via Infotrieve]
37. Ulven, S. M., Gundersen, T. E., Weedon, M. S., Landaas, V. O., Sakhi, A. K., Fromm, S. H., Geronimo, B. A., Moskaug, J. O., and Blomhoff, R. (2000) Dev. Biol. 220, 379-391[CrossRef][Medline] [Order article via Infotrieve]
38. Ang, H. L., and Duester, G. (1997) Dev. Dyn. 208, 536-543[CrossRef][Medline] [Order article via Infotrieve]
39. Kamoda, S., and Saburi, Y. (1993) Biosci. Biotechnol. Biochem. 57, 931-934[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.